DaVita (NYSE:DVA) Shares Gap Up After Earnings Beat

DaVita Inc. (NYSE:DVA) shares gapped up before the market opened on Tuesday following a better than expected earnings announcement. The stock had previously closed at $111.19, but opened at $128.00. DaVita shares last traded at $136.6480, with a volume of 898,090 shares.

The company reported $3.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.24 by $0.16. DaVita had a net margin of 5.80% and a negative return on equity of 13,370.89%. The firm had revenue of $3.62 billion for the quarter, compared to the consensus estimate of $3.51 billion. During the same quarter in the previous year, the firm earned $2.24 EPS. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 13.600-15.00 EPS.

Trending Headlines about DaVita

Here are the key news stories impacting DaVita this week:

• Positive Sentiment: Q4 results beat expectations — DaVita posted ~ $3.29–$3.40 EPS (beat consensus) and revenue of $3.62B, up ~9.9% YoY, driven by steady dialysis demand and improved operating profit. DaVita Inc. 4th Quarter 2025 Results
• Positive Sentiment: Raised FY2026 guidance materially above Street — management set EPS guidance of $13.60–$15.00 vs. the prior consensus (~$12.80), signaling confidence in volume and pricing across its dialysis platform. DaVita forecasts 2026 profit above estimates
• Positive Sentiment: Shares reacted sharply in aftermarket trading after the print and guidance, reflecting strong investor appetite for the beat + upgrade. DaVita shares rise 7% as fourth quarter earnings, revenue beat estimates
• Neutral Sentiment: Analyst/market implications — company guidance exceeds many current sell‑side models (consensus cited lower), so estimates and targets may be revised higher; monitor analyst updates and revisions. MarketBeat DVA profile
• Negative Sentiment: Some underlying metrics deserve scrutiny — net income attributable to common shareholders fell YoY in the quarter and cash & cash equivalents declined; total liabilities rose year-over-year, which could limit flexibility. QuiverQuant Q4 financial details
• Negative Sentiment: Corporate ownership/activity — notable institutional moves (including reductions by large holders) and an eyebrow‑raising negative return-on-equity figure appear in the filings; investors should watch for follow-up commentary. QuiverQuant ownership & metrics

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on DVA shares. Zacks Research upgraded DaVita from a “strong sell” rating to a “hold” rating in a research note on Friday, November 28th. Wall Street Zen lowered DaVita from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Barclays lifted their price objective on shares of DaVita from $143.00 to $158.00 and gave the company an “equal weight” rating in a report on Tuesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of DaVita in a report on Monday, December 29th. Finally, TD Cowen reiterated a “hold” rating on shares of DaVita in a research report on Monday, November 3rd. One research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $148.60.

Institutional Investors Weigh In On DaVita

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Acorn Financial Advisory Services Inc. ADV grew its holdings in shares of DaVita by 10.5% during the 4th quarter. Acorn Financial Advisory Services Inc. ADV now owns 2,230 shares of the company’s stock worth $253,000 after purchasing an additional 212 shares during the period. Intact Investment Management Inc. purchased a new position in DaVita during the fourth quarter worth about $80,000. PFA Pension Forsikringsaktieselskab acquired a new stake in shares of DaVita during the fourth quarter valued at about $1,762,000. State of New Jersey Common Pension Fund D raised its stake in shares of DaVita by 19.7% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 18,504 shares of the company’s stock valued at $2,102,000 after acquiring an additional 3,043 shares during the period. Finally, Interchange Capital Partners LLC lifted its stake in DaVita by 14.6% during the fourth quarter. Interchange Capital Partners LLC now owns 1,801 shares of the company’s stock worth $205,000 after purchasing an additional 229 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 24.6%

The firm has a market capitalization of $9.78 billion, a PE ratio of 14.33, a price-to-earnings-growth ratio of 0.67 and a beta of 0.99. The firm has a 50-day moving average price of $113.42 and a 200 day moving average price of $124.86.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.